Standout Papers

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis 2015 2026 2018 2022 1.5k
  1. Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis (2015)
    Matthew J. Armstrong, Diana Hull et al. Journal of Hepatology
  2. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study (2015)
    Matthew J. Armstrong, Piers Gaunt et al. The Lancet
  3. Non-alcoholic fatty liver disease and diabetes (2016)
    Jonathan Hazlehurst, Conor Woods et al. Metabolism

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

Adipose tissue retains an epigenetic memory of obesity after weight loss
2024 StandoutNature
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
1 intermediate paper

Works of Jonathan Hazlehurst being referenced

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout

Author Peers

Author Last Decade Papers Cites
Jonathan Hazlehurst 1710 608 2055 640 42 3.0k
Bogdan Balas 1536 571 1710 1101 36 3.5k
Darren Barton 1285 634 1609 454 26 2.2k
An Verrijken 945 444 1774 585 75 2.9k
Diana Barb 1396 505 2527 487 31 3.2k
Nicola Villanova 1805 762 3106 497 40 4.1k
Katherine P. Yates 907 662 2016 348 79 3.6k
Robert Bergholm 1455 443 2142 762 33 3.9k
André Grimaldi 1680 655 2395 568 111 3.9k
Arian Afendy 1240 456 2622 545 33 3.2k
Rita Manini 1713 517 2853 490 18 3.4k

All Works

Loading papers...

Rankless by CCL
2026